Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05875142 · ClinicalTrials.gov registry record · NA

Scalable Digital Delivery of Evidence-based Training for Professionals to Maximize Treatment Rates of OUD in Families

A NA study of Substance-Related Disorders and Family Health, sponsored by We The Village.

Completed
Registry status
NA
Development phase
47
Enrollment target
1
Study location

NCT05875142: Completed NA study of Substance-Related Disorders and Family Health, sponsored by We The Village.

NCT05875142 is a NA study of Substance-Related Disorders and Family Health that has completed, run by We The Village. The registered enrollment target is 47 participants, below the 1,520-participant average among 58 other Substance-Related Disorders trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05875142, a NA study of Substance-Related Disorders and Family Health, has completed, sponsored by We The Village.

COMPLETED
Registry status
NA
Development phase
47 participants
Enrollment target
1
Study location

Study Summary

The goal of this project is to develop and evaluate the technical feasibility and commercial viability of a scalable digital counselor training program for CRAFT. This pilot project will develop an enhanced training model for CRAFT and digitize it to maximize scalability. In this project, investigators will: Aim 1: Produce the digital counselor training prototype and coaching process, tailored to OUD - with stakeholder input. Aim 2: Conduct a pilot study of 3 levels of digital training (Level 1 - Digital tutorial only \[T\]; Level 2 - Tutorial \& digital training materials for self-study \[TM\]; Level 3 - Tutorial, digital materials, feedback and coaching \[TMC\]) to establish feasibility, acceptability, and examine the effects of training on CRAFT knowledge, fidelity, and treatment entry and retention.

Primary Outcome

CRAFT performance on the mock sessions was observed by trained coders who rated performance of each CRAFT treatment entry procedure (6 items), homework procedures (2 items), overall CRAFT approach (2 items), and general clinical skill (4 items) on a 5-point scale (i.e., 1 =poor; 3 =satisfactory; 5 =excellent). A total score was calculated across all 14 items for each participant. Average scores on each procedure and in total were calculated for each participant group at baseline and at 12-week f

Interventions

  • BEHAVIORAL Behavioral: Digital Tutorial Overview
  • BEHAVIORAL Behavioral: Training Materials
  • BEHAVIORAL Behavioral: Feedback and Coaching

Study Locations (1)

New York

  • We The Village, Inc. - New York

Trial Details

FieldValue
Enrollment Target 47 participants
Start Date 2023-05-23
Est. Completion 2023-09-26
Phase NA
We The Village

4 total trials

What the finished NCT05875142 record still lists

NCT05875142 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 47 participants, a relatively small participant target, below the 1,520-participant average among 58 other Substance-Related Disorders trials with a reported enrollment target (97% lower).

The record links to 3 conditions, with Substance-Related Disorders appearing as the primary indexed condition, and to 3 interventions - of which Behavioral: Digital Tutorial Overview is the first listed.

NCT05875142 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT05875142 about?

NCT05875142 is a clinical study titled "Scalable Digital Delivery of Evidence-based Training for Professionals to Maximize Treatment Rates of OUD in Families". The goal of this project is to develop and evaluate the technical feasibility and commercial viability of a scalable digital counselor training program for CRAFT. This pilot project will develop an enhanced training model for CRAFT and digitize it to maximize scalability. In this project, investiga...

What is the current status of trial NCT05875142?

This trial is currently completed. It is a NA study. The enrollment target is 47 participants. The study started on 2023-05-23. Estimated completion is 2023-09-26.

What conditions does trial NCT05875142 study?

This clinical trial studies the following conditions: Substance-Related Disorders, Family Health, Community Reinforcement And Family Training.

What interventions are being tested in trial NCT05875142?

The interventions under investigation include: Behavioral: Digital Tutorial Overview (BEHAVIORAL), Behavioral: Training Materials (BEHAVIORAL), Behavioral: Feedback and Coaching (BEHAVIORAL).

Who is sponsoring clinical trial NCT05875142?

This trial is sponsored by We The Village, which has 4 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05875142 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Substance-Related Disorders

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05875142's enrollment target sits among peer trials

47 45th of 58 higher than 14 of 58 other Substance-Related Disorders trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Substance-Related Disorders trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03313011 · 47 participants

    The Neurobiology of Two Distinct Types of Progressive Apraxia of Speech

  • NCT03467516 · 47 participants · Phase 2

    Adoptive Transfer of Tumor Infiltrating Lymphocytes for Metastatic Uveal Melanoma

  • NCT03886662 · 47 participants · Phase 1

    A Study of LB-100 in Patients With Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS)

  • NCT04013802 · 47 participants · Phase 1

    TETRAVI Multivirus CTL for Treatment of EBV, CMV, Adenovirus, and BK Infections Post Allogeneic SCT.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05875142, the US trial registry maintained by the National Library of Medicine. NCT05875142 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.